Skip to main content
padlock icon - secure page this page is secure

Neutral and cationic manganese(II)–diclofenac complexes: structure and biological evaluation

Buy Article:

$63.00 + tax (Refund Policy)

The interaction of MnCl2 with the non-steroidal anti-inflammatory drug sodium diclofenac in the presence of 2,2′-bipyridine and pyridine resulted in the formation of cationic and neutral mononuclear complexes [Mn(diclofenac)(2,2′-bipyridine)(H2O)2] (diclofenac) (1) and [Mn(diclofenac)2(pyridine)2(H2O)2] (2), respectively. The structure of 1 was characterized by X-ray crystallography. In a preliminary attempt to evaluate the biological properties and possible application, the interaction of the complexes with calf-thymus DNA and human or bovine serum albumins was monitored. Additionally, the ability of the compounds to scavenge radicals such as 1,1-diphenyl-picrylhydrazyl, 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid), and hydroxyl radicals was evaluated; the complexes were more potent scavengers than free sodium diclofenac.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Antioxidant activity; Diclofenac; Interaction with DNA; Interaction with albumins; Manganese(II) complexes; Non-steroidal anti-inflammatory drugs

Document Type: Research Article

Affiliations: 1: Laboratory of Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece 2: Faculty of Food Technology and Nutrition, Department of Nutrition and Dietetics, Alexandrion Technological Educational Institution, Thessaloniki, Greece

Publication date: December 17, 2015

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more